Professor Dr. Natalie Trevaskis

Biography

Natalie Trevaskis is the Head of the Lymphatic Medicine Laboratory at the Monash Institute of Pharmaceutical Sciences. Her research group is focused on the role of lymphatics in immune-metabolic diseases and drug delivery systems to treat these conditions. The lymphatic system plays critical physiological roles, including dietary fat absorption and immune response, and is implicated in various diseases such as inflammatory diseases, cancers, and metabolic conditions. Dr. Trevaskis’ work examines how lymphatic dysfunction contributes to diseases like arthritis, pancreatitis, neuroinflammation, atherosclerosis, and type 2 diabetes. Her team develops innovative drug delivery systems, including lipid prodrugs and nano-systems aimed at targeting lymphatics. With over 65 publications and a significant citation record, Dr. Trevaskis has made substantial contributions to the field and received various awards, including the MIPS Future Research Leader Award in 2018 and the AK McIntyre Prize from the Australian Physiological Society in 2015. She is actively involved in academic leadership and professional societies and has contributed numerous invited presentations and symposiums in her area of expertise.

Research Interests

Experience

Awards